Drreddys Laboratories | RDY - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 230K 1.88M 2026-03
Bayer EUR 675M 87M 2025-12
Canopy Growth CAD 12.31M 4.97M 2026-03
Cipla INR 131.3M 9M 2026-03
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Drreddys Laboratories INR 1.06B 113M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
Hikma Pharmaceutical USD 67M 47M 2025-12
Lonza CHF 84M 14M 2025-06
Novartis USD 343M 39M 2026-03
Pacira USD 3.7M 193K 2026-03
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Richter Gedeon HUF 7.5B 9.53B 2024-09
Sun Pharmaceuticals INR 998.6M 250.6M 2025-09
Supernus Pharmaceuticals USD 910K 278K 2023-06
Teva Pharmaceutical Industries USD 216M 4M 2026-03